Universe Pharmaceuticals Inc
4 hedge funds and large institutions have $228K invested in Universe Pharmaceuticals Inc in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
6.65% more ownership
Funds ownership: 0% → 6.65% (+6.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$54.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$46.7K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$20.1K |
| 4 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$39 |
Top Sellers
UPC Hedge Fund Activity: Q2 2026 in Review
4 of the 8,331 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q2 2026, worth a combined $228K.
Buyers outnumbered sellers: 4 funds opened new UPC positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $54.9K.
- 4 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q2 2026, up from 0 in Q1 2026.
- Funds reported $228K of Universe Pharmaceuticals Inc stock for Q2 2026.
- 4 funds opened new Universe Pharmaceuticals Inc positions in Q2 2026 and 0 closed out, a net change of +4 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q2 2026 was HRT Financial, an estimated $54.9K added.
Based on aggregated 13F filings for Q2 2026.